SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-002616
Filing Date
2024-04-23
Accepted
2024-04-23 16:05:35
Documents
17
Period of Report
2024-04-17
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sunshine_8k.htm   iXBRL 8-K 27565
2 CERTIFICATE OF AMENDMENT sunshine_ex0301.htm EX-3.1 15131
6 GRAPHIC image_006.jpg GRAPHIC 138147
7 GRAPHIC image_007.jpg GRAPHIC 45509
  Complete submission text file 0001683168-24-002616.txt   517612

Data Files

Seq Description Document Type Size
3 XBRL DEFINITION FILE sbfm-20240417_def.xml EX-101.DEF 26585
4 XBRL LABEL FILE sbfm-20240417_lab.xml EX-101.LAB 36550
5 XBRL PRESENTATION FILE sbfm-20240417_pre.xml EX-101.PRE 25209
8 XBRL SCHEMA FILE sbfm-20240417.xsd EX-101.SCH 3553
20 EXTRACTED XBRL INSTANCE DOCUMENT sunshine_8k_htm.xml XML 5640
Mailing Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR NEW YORK NY 10036 332-216-1147
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41282 | Film No.: 24864832
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)